- acute myeloid leukemia (AML)
- myelodysplastic syndromes (MDS)
- myeloproliferative neoplasms (MPN)
The focus of Dr. Garcia's research is to develop novel proof-of-concept studies to gain insight on the underlying pathophysiology of acute leukemia and to identify biological predictors of response by partnering with Dana-Farber Cancer Institute laboratory investigators.
- accepting new patients